Neudle.com: dilantin toxicity

Differential
(Click to cross reference)

abducens nerve paralysis

abortion, spontaneous

acetazolamide

acquired immunodeficiency syndrome dementia complex

acute cerebellar ataxia

acute intermittant porphyria

advances in neurology

adverse drug reaction

anemia, megaloblastic

antibiotics, neurologic complications with

anticholinergic drugs

anticholinergic drugs, side effects of

anticholinesterase

anticoagulant, complications of

anticonvulsants

anticonvulsants, absorption

anticonvulsants, bioavailability

anticonvulsants, blood level determination of

anticonvulsants, brand name

anticonvulsants, cognitive function with

anticonvulsants, compliance

anticonvulsants, discontinuation in seizure-free epileptics

anticonvulsants, dosage

anticonvulsants, effectiveness

anticonvulsants, enzyme inducing

anticonvulsants, generic

anticonvulsants, hypersensitivity syndrome

anticonvulsants, loading dose

anticonvulsants, mechanism of action of

anticonvulsants, metabolism

anticonvulsants, parenteral administration

anticonvulsants, pharmacokinetics

anticonvulsants, selection of

anticonvulsants, teratogenicity of

anticonvulsants, untoward effects of

atrioventricular block

Bassen-Kornzweig syndrome

bee sting

bee sting, neurologic complications with

behavioral disorder

benign essential tremor

benzodiazepine

beta adrenergic blocker

blood dyscrasias, neurologic findings with

bone density

bone loss

bone marrow transplantation

burst suppression pattern, electroencephalogram

busulfan

caffeine

calcium antagonist

calcium antagonist, side effects of

carbamazepine, toxicity

central nervous system, infection of

cerebellar ataxia, children

cerebellar ataxia, children, differential diagnosis of

cerebellar atrophy, secondary

cerebellar degeneration

cerebrospinal fluid, elevated protein of

chemotherapy, CNS treatment and complications with

color vision, impaired

congenital birth defects

congenital deformities

congenital heart disease

congenital heart disease, CNS complications with

congenital malformation

congenital malformation, dilantin therapy causing

congenital malformation, non CNS

contrast agents, neurotoxicity of

corpus callosum

corpus callosum, lesion of

creatine phosphokinase(CPK)elevated

developmental evaluation

developmental retardation

diabetes insipidus

digits, abnormal

dilantin

dilantin, factors influencing metabolism of

dilantin, hypersensitivity to

dilantin, intravenous

dilantin, saliva level

dilantin, serum level

dilantin, toxicity

diltiazem

diplopia

disseminated intravascular coagulation(DIC)

drug induced neurologic disorders

drug induced neurologic disorders in children

dyskinesia, buccal lingual facial

electrocardiogram, abnormal

electroencephalogram

electroencephalogram, abnormalities of

electromyogram

embryogenesis

emergencies, neurologic

encephalitis

encephalitis, human immunodeficiency virus type 1

epidemiology of neurology

epilepsy

epilepsy referral centers

eye movement, disorders of

fetal valproate syndrome

fetus

fever

fingernails, abnormal

fingernails, hypoplastic

folic acid antagonists

folic acid deficiency

fosphenytoin

gabapentin

gamma amino butyric acid

gender

generic drugs

genetic counselling

genetic neurologic disorders

hallucination, visual

heavy metal intoxication

hemihyperesthesia

hemiparesis

hemisensory loss

hemorrhagic diathesis

hepatic failure

hepatitis

heralding manifestation

human immunodeficiency virus type 1

hyperactivity

hyperammonemic encephalopathy

hypersensitivity reaction

hypogammaglobulinemia

hypoglycemia

hypospadias

hypotension, systemic

hypoxia

iatrogenic neurologic disorders

intelligence quotient

intelligence testing in children

level of consciousness, decreased

liver function enzymes

lorazepam

lordosis

lymphadenopathy

malformation, CNS, congenital

malignant hyperpyrexia

manic-depressive

marihuana

memory, impairment of

meningitis

menses, seizure with

mental retardation

mental status, abnormal

mexiletine

microcephaly

midline defect in children

movement disorder, drug induced

movement disorder, extrapyramidal

movement disorder, treatment of

MRI

MRI, abnormal

MRI, disappearing lesion on

muscle weakness, proximal

myasthenia gravis

myasthenia gravis, drug induced

myasthenia gravis, unmasked

myopathy, drug-induced

myotonia, treatment of

neuromuscular blockade

neuromuscular junction, abnormality of

neuropathy

neuropathy, iatrogenic

neuropathy, medication induced

neuropathy, peripheral

nystagmus, periodic alternating

nystagmus, primary position of gaze

obstetric neurologic injuries

ocular motility, disorders of

oculocephalic reflex

oculovestibular reflex

old age, neurology of

ophthalmoplegia

ophthalmoplegia, total

optic neuritis

optokinetic nystagmus(O.K.N.)

oral contraceptives

oral contraceptives, neurologic complications with

pain, management of chronic

paraldehyde

paramethadione

paroxetine

patient information and support

penicillamine

penicillin

percussion induced muscle contraction

periarteritis nodosa

personality disorder

phantom limb

phencyclidine poisoning

poison, neurologic problems with

polydactyly

polymyositis

polypharmacy

postoperative neurologic complications

practice guidelines

pregabalin

pregnancy, anticonvulsants during

pregnancy, neurologic complications in

prenatal

prenatal diagnosis by amniocentesis

prevention of neurologic disorders

psychiatric problems in neurologic disorders

psychological testing

psychological testing, children

psychomotor retardation

psychosis

ptosis

pulmonary edema

pulmonary function tests

pulmonary infiltrates

pupil, dilated, bilateral

Purkinje cell

purple glove syndrome

respiratory depression

respiratory failure

respiratory paralysis, pharmacologic

review article

rhabdomyolysis

rheumatoid arthritis, neurologic complications of

seizure, breakthrough

seizure, children

seizure, classification of

seizure, complications following

seizure, diagnosis of

seizure, differential diagnosis of

seizure, drug-induced

seizure, elderly

seizure, focal

seizure, intractable

seizure, intractable, treatment of

seizure, maternal

seizure, minor motor

seizure, non-treatment of

seizure, paradoxical

seizure, petit mal

seizure, post traumatic

seizure, pregnancy

seizure, prevention of

seizure, prognosis in childhood

seizure, psychomotor-temporal lobe

seizure, psychosocial aspects of

seizure, recurrent

seizure, surgical treatment of

seizure, tonic-clonic

seizure, treatment of

seizure, treatment of, first

seizure, treatment of, monotherapy

seizure, treatment of, polytherapy

seizure, withdrawal

seizure, women

seizure, workup of

selective serotonin reuptake inhibitors

sertraline

serum glutamic oxaloacetic transaminase

serum sickness

sexual dysfunction in neurologic disease

skin, lesions in neurologic disorders

sodium valproate

sodium valproate, intravenous

sodium valproate, toxicity

somnolence

sore throat

spina bifida

splenium of corpus callosum

statin therapy

status epilepticus

steroid

Stevens-Johnson syndrome

stillbirth

subarachnoid hemorrhage

sympathomimetic drugs

systemic lupus erythematosus, drug induced

temporal lobe, status

toxic epidermal necrolysis

toxins, nervous system

trauma

treatment of neurologic disorder

tremor

tremor, cerebellar

tremor, classification

tremor, differential diagnosis of

tremor, intention

tremor, rubral

trigeminal neuralgia

trigeminal neuralgia, treatment of

trimethadione

trimethoprim-sulfamethoxazole

ultrasonography

ultrasonography, head, fetus-neonate

vitamin supplementation

Showing articles 2750 to 2800 of 5240 << Previous Next >>

Association of Primary Central Nervous System Lymphoma with Long-Term Azathioprine Therapy for Myasthenia Gravis?
Ann Neurol 47: 682-683, Herrlinger,U.,et al, 2000

Tonic Seizures are a Particular Risk Factor for Drowning in People with Epilepsy
BMJ 321:975-976, Besag,F.M.C., 2000

A 5-Month, Randomized, Placebo-controlled Trial of Galantamine in AD
Neurol 54:2269-2276, Tariot,P.N.,et al, 2000

Galantamine in AD
Neurol 54:2261-2268, Raskind,M.A.,et al, 2000

Diffusion-Weighted Magnetic Resonance Imaging in a Case of Methanol Intoxication
Neurotoxicology 21:405-408, Oppenheim, D.S.,et al, 2000

Bicuspid Aortic Valve - A Silent Danger: Analysis of 50 Cases of Infective Endocarditis
Clin Inf Dis 30:336-341, Lamas, C.C. & Eykyn, S.J., 2000

Guillain-Barre Syndrome in a Patient with Non-Hodgkins Lymphoma
Ann Oncol 11:217-220, Schwenk,D.Re.,et al, 2000

Isolated Angiitis of the Central Nervous System:Lack of Inflammation after Long-Term Treatment
Neurol 52:196-199, Reimer,G.,et al, 1999

Risk of Cerebral Angiography in Patients with Subarachnoid Hemorrhage,Cerebral Aneurysm,and Arteriovenous Malformation,A Meta-Analysis
Stroke 30:317-320, Cloft,H.J.,et al, 1999

Frequency of Major Complications of Aspirin,Warfarin,and Intravenous Heparin for Secondary Stroke Prevention,A Population-Based Study
Ann Int Med 130:14-22, Petty,G.W.,et al, 1999

Cerebral Venous Thrombosis,Combined Intrathrombus rtPA and Intravenous Heparin
Stroke 30:489-494,481, Frey,J.L.,et al, 1999

Pseudochoreoathetosis in Four Patients with Hypesthetic Ataxic Hemiparesis in a Thalamic Lesion
J Neurol 246:1075-1079, Kim, J.W., et al, 1999

Herbal Remedies: Adverse Effects and Drug Interactions
Am Fam Physician 59:1239-1244, Cupp, M.J.,et al, 1999

Leukoencephalopathy and Raised Brain Lactate from Heroin Vapor Inhalation ("Chasing the Dragon")
Neurol 53:589-1048, Kriegstein,A.R., et al, 1999

Evaluation of Metronidazole Toxicity: A Prospective Study
Int J Clin Pharmacol Res 19:83-88, Kapoor,K.,et al, 1999

Femoral Neuropathy Following Cardiac Catheterization for Balloon Mitral Valvotomy
Int J Cardiol 71:197-198, Kuruvilla,A.,et al, 1999

Bilateral Posterior Ischemic Optic Neuropathy After Spinal Surery
Am J Ophthal 127:354-355, Alexandrakis,G.&Lam,B.L., 1999

Prevalence of Peripheral Neuropathy in Injection Drug Users
Neurol 53:592-597, Berger,A.R.,et al, 1999

Phenobarbital Compared with Phenytoin for the Treatment of Neonatal Seizures
NEJM 341:485-489, Painter,M.J.,et al, 1999

Safety and Efficacy of Vigabatrin and Carbamazepine in Newly Diagnosed epilepsy:A Multicentre Randomised Double-Blind Study
Lancet 354:13-19, Chadwick,D., 1999

Sudden Unexpected Death in epilepsy (SUDEP): A Clinical Perspective and a Search for Risk Factors
JNNP 67:439-444,427, Kloster,R.&Engelskjon,T., 1999

Psychiatric Adverse Events During Vigabatrin Therapy
Neurol 53:1503-1511, Levinson,D.F.&Devinsky,O., 1999

Long-Term Treatment with Vagus Nerve Stimulation in Patients with Refractory Epilepsy
Neurol 53:1731-1735, Morris,G.L.,et al, 1999

The Intensive Care Management of Acute Ischemic Stroke
The Neurologist 5:313-325, Deibert,E.&Diringer,M.N., 1999

Intra-Arterial Prourokinase for Acute Ischemic Stroke, The PROACT II Study:A Randomized Controlled Trial
JAMA 282:2003-2011, Furlan,A.,et al, 1999

Recombinant Tissue-Type Plasminogen Activator (Alteplase) for Ischemic Stroke 3 to 5 Hours After Symptom Onset, The ATLANTIS Study:A Randomized Controlled Trial
JAMA 282:2019-2026, Clark,W.M.,et al, 1999

Diagnosis and Treatment of Wilson's Disease
Semin Neurol 19:261-270, Brewer,G.J.,et al, 1999

Gastric Tolerance of High-Dose Pulse Oral Prednisone in Multiple Sclerosis
Neurol 53:2093-2096, Metz,L.M.,et al, 1999

Diffuse Cerebral Vasculitis with Normal Results on Brain MR Imaging
AJR 173:1494-1496, Imbesi,S.G., 1999

Intravenous Immunoglobulin in the Treatment of Autoimmune Neuromuscular Diseases:Present Status and Practical Therapeutic Guidelines
Muscle & Nerve 22:1479-1497, Dalakas,M.C., 1999

Visual Field Defects Associated with Vigabatrin Therapy
JNNP 67:716-722, Lawden,M.C.,et al, 1999

Gabapentin-Induced Anorgasmia
Neurol 53:2209, Clark,J.D.&Elliott,J., 1999

Effectiveness of Anticholinergics and Neuroleptic Dose Reduction on Neuroleptic-Induced Pleurothotonus (the Pisa Syndrome)
J Clin Psychopharmacol 19:277-280, Suzuki,T.,et al, 1999

Oxcarbazepine: Double-blind, Randomized, Placebo-control, Monotherapy Trial for Partial Seizures
Neurol 52:732-737, Schachter,S.C. et al, 1999

Efficient Operation of a High-Volume Anticoagulation Clinic
Am J Health Syst Pharm 56:443-449, Foss,M.T.,et al, 1999

Cognitive Effects of Topiramate,Gabapentin,And Lamotrigine in Healthy Young Adults
Neurol 52:321-327, Martin,R.,et al, 1999

The Association of the Combination of Sumatriptan and Methysergide in Myocardial Infarction in a Premenopausal Woman
Arch Int Med 159:511-513, Liston,H.,et al, 1999

Treatment of Attention-Deficit-Hyperactivity Disorder
NEJM 340:780-788, Elia,J.,et al, 1999

Low-Dose Clozapine for the Treatment of Drug-Induced Psychosis in Parkinson's Disease
NEJM 340:757-763,801, The Parkinson Study Group, 1999

Neurologic Side Effects in Neuroleptic-Naive Patients Treated with Haloperidol or Risperidone
Neurol 52:782-785, Rosebush,P.I.&Mazurek,M.F., 1999

Spastic Paraparesis after Anaesthesia
Lancet 353:554, Lee,P.,et al, 1999

Churg-Strauss Syndrome, Clinical Study and Long-Term Follow-Up of 96 Patients
Medicine 78:26-37, Guillevin,L.,et al, 1999

Diagnosis and Treatment of Ischemic Stroke
Am J Med 106:211-221, Alberts,M.J., 1999

Intracranial Internal Carotid Artery Angioplasty:Technique with Clinical and Radiographic Results and Follow-Up
AJR 172:703-707, Eckard,D.A.,et al, 1999

Efficacy and Safety of Rivastigmine in Patients with Alzheimer's Disease:International Randomised Controlled
BMJ 318:633-640, 615, Rosler,M.,et al, 1999

Medical Management of Epilepsy in Adults
Neurol 51:S15-S20, Mattson,R.H., 1999

Risk Factors for Sudden Unexpected Death in epilepsy:A Case-Control Study
Lancet 353:888-893, Nilsson,L.,et al, 1999

Choosing Antithrombotic Therapy for Elderly Patients with Atrial Fibrillation Who are at Risk for Falls
Arch Int Med 159:677-685, Man-Son-Hing,M.,et al, 1999

Evidence of Anaphylaxy after Alteplase Infusion
Stroke 30:1142-1143, Rudolf,J.,et al, 1999

Risk of Primary Intracerebral Haemorrhage Associated with Aspirin and Non-Steroidal Anti-Inflammatory Drugs:Case-Control Study
BMJ 318:759-764, Thrift,A.G.,et al, 1999

Showing articles 2750 to 2800 of 5240 << Previous Next >>